Carregant...
Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
In oncology, an increasing number of targeted anticancer agents and immunotherapies are of biological origin. These biological drugs may trigger immune responses that lead to the formation of antidrug antibodies (ADAs). ADAs are directed against immunogenic parts of the drug and may affect efficacy...
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061540/ https://ncbi.nlm.nih.gov/pubmed/27440064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0061 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|